Allylestrenol

็ƒฏไธ™้›Œ้†‡

Report date: 2023/03/22 15:06:08
NME

Base Information

Drug NameAllylestrenol
Drug Alias Namealilestrenol17-็ƒฏไธ™ๅŸบ้›Œ็ƒฏ้†‡allylestrenolum็ƒฏไธ™ๅŸบ้›Œ็ƒฏ้†‡็ƒฏไธ™้›Œ็ƒฏ้†‡ +[7]ย 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonists
TargetsProgesterone receptor
Therapy Area/IndicationsObstetric Labor, PrematureProstatic Hyperplasia
Global Approved IndicationsObstetric Labor, PrematureProstatic Hyperplasia
Approved Indications in ChinaObstetric Labor, Premature
Original Approved Country/TerritoryJapan
Original Approved Date1996/01/23
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGedeon Richter Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsObstetric Labor, PrematureProstatic Hyperplasia
Inactive IndicationsN/A

Other Information

ATC CodeG03DC01